Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ALPHA HEALTHCARE ACQUISITION CORP III | 76 878 | déclaré | 11 oct. 2024 | tx 11+169 720 |
| HOME DIAGNOSTICS INC | 0 | déclaré | 15 mars 2010 | tx 8+67 000−67 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 11 oct. 2024 | GRANT_AWARD | ALPHA HEALTHCARE ACQUISITION CORP III | 76 878 | 0.00 USD | deriv |
| 13 sept. 2024 | PURCHASE | ALPHA HEALTHCARE ACQUISITION CORP III | 5 000 | 0.47 USD | |
| 20 août 2024 | PURCHASE | ALPHA HEALTHCARE ACQUISITION CORP III | 3 600 | 0.89 USD | |
| 12 juin 2024 | PURCHASE | ALPHA HEALTHCARE ACQUISITION CORP III | 2 000 | 2.20 USD | |
| 23 sept. 2021 | OTHER | ALPHA HEALTHCARE ACQUISITION CORP III | 0 | 0.00 USD | |
| 12 déc. 2023 | PURCHASE | ALPHA HEALTHCARE ACQUISITION CORP III | 2 000 | 3.50 USD | |
| 23 sept. 2021 | OTHER | ALPHA HEALTHCARE ACQUISITION CORP III | 0 | 0.00 USD | |
| 13 déc. 2023 | PURCHASE | ALPHA HEALTHCARE ACQUISITION CORP III | 2 400 | 3.47 USD | |
| 14 juil. 2023 | OTHER | ALPHA HEALTHCARE ACQUISITION CORP III | 69 | — | deriv |
| 14 juil. 2023 | OTHER | ALPHA HEALTHCARE ACQUISITION CORP III | 895 | — | deriv |
| 14 juil. 2023 | GRANT_AWARD | ALPHA HEALTHCARE ACQUISITION CORP III | 76 878 | — | deriv |
| 15 mars 2010 | OTHER | HOME DIAGNOSTICS INC | 8 500 | 0.00 USD | deriv |
| 15 mars 2010 | OTHER | HOME DIAGNOSTICS INC | 21 000 | 0.00 USD | deriv |
| 15 mars 2010 | OTHER | HOME DIAGNOSTICS INC | 24 000 | 0.00 USD | deriv |
| 15 mars 2010 | OTHER | HOME DIAGNOSTICS INC | 13 500 | 0.00 USD | deriv |
| 05 mai 2009 | GRANT_AWARD | HOME DIAGNOSTICS INC | 24 000 | 0.00 USD | deriv |
| 02 juin 2008 | GRANT_AWARD | HOME DIAGNOSTICS INC | 21 000 | 0.00 USD | deriv |
| 05 juin 2007 | GRANT_AWARD | HOME DIAGNOSTICS INC | 13 500 | 0.00 USD | deriv |
| 26 sept. 2006 | GRANT_AWARD | HOME DIAGNOSTICS INC | 8 500 | 0.00 USD | deriv |